Cargando…

The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions

Mycobacterium leprae infection of peripheral nerves and the subsequent nerve function impairment (NFI), especially in response to reactional episodes, are hallmarks of leprosy. Improved treatments for M. leprae-induced nerve injury are needed, as most if not all of the disability and stigma associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pena, Maria Teresa, Lahiri, Ramanuj, Ebenezer, Gigi J., Wheat, Stephen W., Figarola, John, Truman, Richard W., Adams, Linda B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259846/
https://www.ncbi.nlm.nih.gov/pubmed/35814754
http://dx.doi.org/10.3389/fmed.2022.879097
_version_ 1784741876120682496
author Pena, Maria Teresa
Lahiri, Ramanuj
Ebenezer, Gigi J.
Wheat, Stephen W.
Figarola, John
Truman, Richard W.
Adams, Linda B.
author_facet Pena, Maria Teresa
Lahiri, Ramanuj
Ebenezer, Gigi J.
Wheat, Stephen W.
Figarola, John
Truman, Richard W.
Adams, Linda B.
author_sort Pena, Maria Teresa
collection PubMed
description Mycobacterium leprae infection of peripheral nerves and the subsequent nerve function impairment (NFI), especially in response to reactional episodes, are hallmarks of leprosy. Improved treatments for M. leprae-induced nerve injury are needed, as most if not all of the disability and stigma associated with leprosy arises from the direct or indirect effects of NFI. Nine-banded armadillos (Dasypus novemcinctus), like humans, exhibit the full clinical spectrum of leprosy and extensive involvement of the peripheral nerves. In this study, state-of-the-art technology was used to compare nerve function between uninfected and M. leprae-infected armadillos. Motor nerve conduction velocity (MNCV) and compound muscle action potential (cMAP), which measure changes in the rate of impulse conduction velocity and amplitude, revealed a progression of impairment that was directly correlated with the duration of M. leprae infection and enabled development of an objective nerve impairment scoring system. Ultrasonography accompanied by color Doppler imaging detected enlargement of the M. leprae-infected nerves and increased vascularity, possibly due to inflammation. Assessment of epidermal nerve fiber density (ENFD), which shows a length-dependent innervation in armadillos that is similar to humans, identified small fiber degeneration early after M. leprae infection. Staining for neuromuscular junction (NMJ) integrity, which is an indicator of signal transduction efficiency into skeletal muscle, discerned a markedly lower number and structural integrity of NMJ in M. leprae-infected armadillo footpads. These tools for assessing nerve injury were used to monitor the effects of intervention therapy. Two potential neuro-protective drugs, ethoxyquin (EQ) and 4-aminopyridine (4-AP), were tested for their ability to ameliorate peripheral nerve injury in M. leprae-infected armadillos. 4-AP treatment improved MNCV, cMAP, and EFND compared to untreated animals, while EQ had less effect. These results support the armadillo as a model for M. leprae-induced peripheral nerve injury that can provide insights toward the understanding of NFI progression and contribute to the preclinical investigation of the safety and efficacy of neuro-preventive and neuro-therapeutic interventions for leprosy.
format Online
Article
Text
id pubmed-9259846
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92598462022-07-08 The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions Pena, Maria Teresa Lahiri, Ramanuj Ebenezer, Gigi J. Wheat, Stephen W. Figarola, John Truman, Richard W. Adams, Linda B. Front Med (Lausanne) Medicine Mycobacterium leprae infection of peripheral nerves and the subsequent nerve function impairment (NFI), especially in response to reactional episodes, are hallmarks of leprosy. Improved treatments for M. leprae-induced nerve injury are needed, as most if not all of the disability and stigma associated with leprosy arises from the direct or indirect effects of NFI. Nine-banded armadillos (Dasypus novemcinctus), like humans, exhibit the full clinical spectrum of leprosy and extensive involvement of the peripheral nerves. In this study, state-of-the-art technology was used to compare nerve function between uninfected and M. leprae-infected armadillos. Motor nerve conduction velocity (MNCV) and compound muscle action potential (cMAP), which measure changes in the rate of impulse conduction velocity and amplitude, revealed a progression of impairment that was directly correlated with the duration of M. leprae infection and enabled development of an objective nerve impairment scoring system. Ultrasonography accompanied by color Doppler imaging detected enlargement of the M. leprae-infected nerves and increased vascularity, possibly due to inflammation. Assessment of epidermal nerve fiber density (ENFD), which shows a length-dependent innervation in armadillos that is similar to humans, identified small fiber degeneration early after M. leprae infection. Staining for neuromuscular junction (NMJ) integrity, which is an indicator of signal transduction efficiency into skeletal muscle, discerned a markedly lower number and structural integrity of NMJ in M. leprae-infected armadillo footpads. These tools for assessing nerve injury were used to monitor the effects of intervention therapy. Two potential neuro-protective drugs, ethoxyquin (EQ) and 4-aminopyridine (4-AP), were tested for their ability to ameliorate peripheral nerve injury in M. leprae-infected armadillos. 4-AP treatment improved MNCV, cMAP, and EFND compared to untreated animals, while EQ had less effect. These results support the armadillo as a model for M. leprae-induced peripheral nerve injury that can provide insights toward the understanding of NFI progression and contribute to the preclinical investigation of the safety and efficacy of neuro-preventive and neuro-therapeutic interventions for leprosy. Frontiers Media S.A. 2022-06-23 /pmc/articles/PMC9259846/ /pubmed/35814754 http://dx.doi.org/10.3389/fmed.2022.879097 Text en Copyright © 2022 Pena, Lahiri, Ebenezer, Wheat, Figarola, Truman and Adams. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Pena, Maria Teresa
Lahiri, Ramanuj
Ebenezer, Gigi J.
Wheat, Stephen W.
Figarola, John
Truman, Richard W.
Adams, Linda B.
The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions
title The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions
title_full The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions
title_fullStr The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions
title_full_unstemmed The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions
title_short The Armadillo as a Model for Leprosy Nerve Function Impairment: Preventative and Therapeutic Interventions
title_sort armadillo as a model for leprosy nerve function impairment: preventative and therapeutic interventions
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259846/
https://www.ncbi.nlm.nih.gov/pubmed/35814754
http://dx.doi.org/10.3389/fmed.2022.879097
work_keys_str_mv AT penamariateresa thearmadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT lahiriramanuj thearmadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT ebenezergigij thearmadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT wheatstephenw thearmadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT figarolajohn thearmadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT trumanrichardw thearmadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT adamslindab thearmadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT penamariateresa armadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT lahiriramanuj armadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT ebenezergigij armadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT wheatstephenw armadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT figarolajohn armadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT trumanrichardw armadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions
AT adamslindab armadilloasamodelforleprosynervefunctionimpairmentpreventativeandtherapeuticinterventions